Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

MSCI Emerging Markets Index / Technical Analysis

EM equities remain long-term leadership despite giving up some ground over the last month to developed markets. Given the intact relative strength uptrend, we reiterate our overweight EM recommendation. Energy and Health Care stocks are outperforming and remain attractive. Technology is consolidating and we would use recent weakness as a buying opportunity. Today’s report includes a wide variety of bottom-up recommendations, spanning most sectors and all market capitalizations.

EM equities remain long-term leadership despite giving up some ground over the last month to developed markets. Given the intact relative strength uptrend, we reiterate our overweight EM recommendation. Energy and Health Care stocks are outperforming and remain attractive. Technology is consolidating and we would use recent weakness as a buying opportunity. Today’s report includes a wide variety of bottom-up recommendations, spanning most sectors and all market capitalizations.

EM Strategy: Overweight Technology, Energy, and Health Care.

Asean-focused. Ex-Head of Thai Research

Athaporn Arayasantiparb, CFA

Asean (Thailand) Focused Independent Research

M Corp Review

M Corp is led by Athaporn Arayasantiparb who served as Head of Research for UOB and ANZ in Thailand and was an award-winning telecoms analyst at UBS in 2010 (AsiaMoney Thailand category) and Regional Strategist for DMG in Singapore. Prior to that, he also served as Kasikornbank credit analyst and scholar. He has a total work experience of 17 years, of which 14 were in research and 4 in research management roles. He started his career as an engineer for PTT and currently manages family investments. He holds an MBA from Stern (NYU) and CFA Charter since 2006. Apart from IPO Radar, which focuses on future listings, MCorp Review also provides six on-going thematic series ranked by frequency in descending order, namely: 1) Silicon Stories (technology) 2) Sathorn Series (financial services) 3) Thai-Coons (billionaire origin stories) 4) Reality Check (data-driven, investigative) 5) Thai Media Spotlight; and 6) Thai Macro Watch (global market drivers).

Equity Bottom-Up

Bangkok Chain Hospital / Equity Bottom-Up

We spent three days at BCH (Bangkok Chain Hospital)'s Kasemraj Bangkhae branch while waiting for my mom to recover and share some of our observations about the firm's operations on-the-ground with you in this review. For those of you considering to buy the stock or simply want to know a little more about the company, we hope you find this useful.  <a href="https://www.smartkarma.com/companies/339" target="_blank" data-smartkarma-citation="companies:339">A. Stotz Investment Research</a> has already provided quite a detailed big picture description of the firm and its financial outlook as highlighted in the…

We spent three days at BCH (Bangkok Chain Hospital)'s Kasemraj Bangkhae branch while waiting for my mom to recover and share some of our observations about the firm's operations on-the-ground with you in this review. For those of you considering to buy the stock or simply want to know a little more about the company, we hope you find this useful.  A. Stotz Investment Research has already provided quite a detailed big picture description of the firm and its financial outlook as highlighted in the…

Equity Capital Markets

Thonburi Healthcare Group / Equity Capital Markets

Investors, both Thai and Canadian, seem crazy about healthcare. We caught wind that a small player, Thonburi (THG), could be listed some time this year. Using two different methods, MCorp Review estimate that the stock is worth between Bt11.8/sh to Bt17.4/sh, so we might be willing to take a plunk if it doesn't IPO too close to the top of the range. Healthcare stocks typically trade at one of the highest multiples in Thai markets, so you're lucky if you can get it cheap.Founded by the Vanasin family, these guys are not healthcare elites yo. Returns are generally lower than the big boys, and it's probably more like a hospital for locals. In fact, Thonburi is the poorer side of Bangkok.

Investors, both Thai and Canadian, seem crazy about healthcare. We caught wind that a small player, Thonburi (THG), could be listed some time this year. Using two different methods, MCorp Review estimate that the stock is worth between Bt11.8/sh to Bt17.4/sh, so we might be willing to take a plunk if it doesn't IPO too close to the top of the range. Healthcare stocks typically trade at one of the highest multiples in Thai markets, so you're lucky if you can get it cheap.Founded by the Vanasin family, these guys are not healthcare elites yo. Returns are generally lower than the big boys, and it's probably more like a hospital for locals. In fact, Thonburi is the poorer side of Bangkok.

IPO Radar: Thonburi, Scruffy Hospital from the West Side Yo!

ASEAN Insight Provider, CrossASEAN Research

Angus Mackintosh

ASEAN Insight Provider

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Thematic (Sector/Industry)

This week has been a tough one for the people of Jakarta, as the outgoing Governor was handed an extremely dubious sentence of two years in jail, on an even more dubious trumped up charge of blasphemy. According to some interesting post-election analysis, Ahok lost squarely because of this case. A large number of voters, who approved of the great work he had done in Jakarta, moved to vote against him due to the religious angle (as well as some intimidation it seems).Even though President Jokowi…

This week has been a tough one for the people of Jakarta, as the outgoing Governor was handed an extremely dubious sentence of two years in jail, on an even more dubious trumped up charge of blasphemy. According to some interesting post-election analysis, Ahok lost squarely because of this case. A large number of voters, who approved of the great work he had done in Jakarta, moved to vote against him due to the religious angle (as well as some intimidation it seems).Even though President Jokowi…

The Week that Was in ASEAN@Smartkarma - Ghostowns, Thaksinites and Casinos

The Crusade against Obamacare. Back in St Louis, a long-shot Republican candidate managed to make Hillary, who is a great debater in our books ( <a href="https://www.smartkarma.com/insights/second-take-on-second-debate-hillary-1-trump-1" target="_blank" data-smartkarma-citation="insights:6481">Second Take on Second Debate: Hillary 1, Trump 1</a>), to admit that in some contexts (probably healthy people), Obamacare was making healthcare insurance more expensive. Today, that candidate is in the White House, and the Republicans are seriously pushing to get Obamacare repealed. Basically, CNN explained Obamacare in layman terms as expanding coverage…

The Crusade against Obamacare. Back in St Louis, a long-shot Republican candidate managed to make Hillary, who is a great debater in our books ( Second Take on Second Debate: Hillary 1, Trump 1), to admit that in some contexts (probably healthy people), Obamacare was making healthcare insurance more expensive. Today, that candidate is in the White House, and the Republicans are seriously pushing to get Obamacare repealed. Basically, CNN explained Obamacare in layman terms as expanding coverage…

Thailand

Bangkok Dusit Medical Services Public Company Limited operates Bangkok General Hospital. The Hospital specializes in cardiovascular, lung, neurological, eye and genitourinary cancer, as well as physical therapy and medical imaging.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bangkok Dusit Medical Services (BDMS TB)

EM Strategy: Overweight Technology, Energy, and Health Care.

EM equities remain long-term leadership despite giving up some ground over the last month to developed markets. Given the intact relative strength...

Vermilion Research

On the Ground Observations at BCH

We spent three days at BCH (Bangkok Chain Hospital)'s Kasemraj Bangkhae branch while waiting for my mom to recover and share some of our...

Athaporn Arayasantiparb, CFA

IPO Radar: Thonburi, Scruffy Hospital from the West Side Yo!

Investors, both Thai and Canadian, seem crazy about healthcare. We caught wind that a small player, Thonburi (THG), could be listed some time this...

Athaporn Arayasantiparb, CFA

The Week that Was in ASEAN@Smartkarma - Ghostowns, Thaksinites and Casinos

This week has been a tough one for the people of Jakarta, as the outgoing Governor was handed an extremely dubious sentence of two years in jail,...

Angus Mackintosh

Obamacare Repeal & Thai Stocks

The Crusade against Obamacare. Back in St Louis, a long-shot Republican candidate managed to make Hillary, who is a great debater in our books (...

Athaporn Arayasantiparb, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)